Past two years Past Year Past 30 Days
Abstract Views 80 61 2
Full Text Views 1 0 0
PDF Downloads 3 0 0
 
 
 
 
 
 
 
 
 
 
 

A Further Study of the Toxicity of Pyrimethamine (Daraprim) in Man

A. V. MyattLaboratory of Tropical Diseases, National Microbiological Institute, National Institutes of Health, Bethesda 14, Maryland

Search for other papers by A. V. Myatt in
Current site
Google Scholar
PubMed
Close
,
G. Robert CoatneyLaboratory of Tropical Diseases, National Microbiological Institute, National Institutes of Health, Bethesda 14, Maryland

Search for other papers by G. Robert Coatney in
Current site
Google Scholar
PubMed
Close
,
Thomas HernandezLaboratory of Tropical Diseases, National Microbiological Institute, National Institutes of Health, Bethesda 14, Maryland

Search for other papers by Thomas Hernandez in
Current site
Google Scholar
PubMed
Close
, and
Herbert W. BurtonLaboratory of Tropical Diseases, National Microbiological Institute, National Institutes of Health, Bethesda 14, Maryland

Search for other papers by Herbert W. Burton in
Current site
Google Scholar
PubMed
Close
View More View Less
Restricted access

Summary and Conclusions

Reported therapeutic tests show that pyrimethamine is an effective suppressant for malaria in dosage of 25 mg. single dose weekly. Our studies reported here and previously (Coatney et al., 1953) indicate that this dosage may be given safely to white or colored races without untoward reactions, barring possible cases of idiosyncrasy.

Save